Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Transmembrane domain–driven PD-1 dimers mediate T cell inhibition

Science Immunology(2024)10.1126/sciimmunol.ade6256Source: DataRank Database

Transmembrane domain–driven PD-1 dimers mediate T cell inhibition is a research paper published in Science Immunology (2024). On theSindex it has a DataRank of 0. It has been cited 43 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access43 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (10 grants)Impact (FWCI 8.06)OA: bronzeTopics (34)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (19)

Jia Liu ORCID,Audun Kvalvaag ORCID,Alexander M. Mørch ORCID,Anna S. Tocheva ORCID,Charles Ng ORCID

Live enrichment

PubMed:38457513 PMC:PMC11166110 OpenAlex:https://openalex.org/W4392581923

NCI NIH HHS

Grant: R01 CA269898

NIGMS NIH HHS

Grant: T32 GM007308

Kennedy Trust

Grant: KENN202114

NIAID NIH HHS

Grant: R01 AI125640

NIAMS NIH HHS

Grant: T32 AR069515

NCI NIH HHS

Grant: R37 CA273333

NCI NIH HHS

Grant: P50 CA225450

Kennedy Trust

Grant: KENN202117

Wellcome Trust

FWCI

8.06

Citation Percentile

1.0%

Citation Trend

2024

2025

2026

bronze

journalhttps://www.science.org/doi/pdf/10.1126/sciimmunol.ade6256?download=true

publisherhttps://www.science.org/doi/pdf/10.1126/sciimmunol.ade6256?download=true

publisherhttps://www.science.org/doi/pdf/10.1126/sciimmunol.ade6256

journalhttps://doi.org/10.1126/sciimmunol.ade6256

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38457513

Fields of Study

Cancer Immunotherapy and BiomarkersImmune Cell Function and InteractionImmunotherapy and Immune ResponsesHumansProgrammed Cell Death 1 ReceptorNeoplasmsImmune ToleranceLymphocyte ActivationProtein DomainsAutoimmune Diseases

MeSH Terms

Protein DomainsAutoimmune DiseasesHumansImmune ToleranceLymphocyte ActivationNeoplasmsProgrammed Cell Death 1 Receptor

Keywords

Immune systemCytotoxic T cellReceptorT cellImmunotherapyTransmembrane proteinImmune checkpointCell biologyAutoimmune diseaseImmunologyBiologyPD-L1Cancer researchChemistryBiochemistryAntibodyIn vitro

Sustainable Development Goals

SDG 0: Good health and well-being